More than 60 peptide API products cover key therapeutic areas including endocrine, oncology, gastrointestinal and cardiovascular fields, with several core products filed or approved in multiple countries.
Core products with FDA DMF / NMPA registration / EMA CEP status are available for commercial-scale supply.
| Therapeutic Area | Product | CAS | DMF / Registration No. |
|---|---|---|---|
| Endocrine | Tirzepatide | — | FDA: 039655 |
| Liraglutide | 204656-20-2 | FDA: 035972 MFDS: 20241014-210-J-1716 | |
| Cagrilintide | 1415456-99-3 | — | |
| Retatrutide | 2381089-83-2 | — | |
| Ganirelix Acetate | 129311-55-3 | NMPA: Y20240000395 | |
| Oncology | Leuprorelin Acetate | 74381-53-6 | NMPA: Y20200000344 FDA: 035071 EMA: R0-CEP 2020-305-Rev 00 |
| Gastrointestinal | Linaclotide | 851199-59-2 | FDA: 042049 |
← Swipe horizontally to view the full table →
Pipeline and reserve products grouped by therapeutic area. We welcome cooperation in process development, registration and commercial supply.
| Therapeutic Area | Product | CAS |
|---|---|---|
| Others | Difelikefalin Acetate | 1024829-44-4 |
| Etelcalcetide Hydrochloride | 1334237-71-6 | |
| Bivalirudin | 128270-60-0 | |
| Edotreotide | 204318-14-9 | |
| Angiotensin II | 4474-91-3 | |
| Ziconotide Acetate | 107452-89-1 | |
| Dynorphin A (1-13) | 72957-38-1 | |
| Angiotensin | 20071-00-5 | |
| Vasopressin | 11000-17-2 | |
| Elcatonin | 60731-46-6 | |
| Vapreotide | 103222-11-3 | |
| Secretin | 10813-74-8 | |
| Protirelin / Sincalide | 24305-27-9 / 25126-32-3 | |
| Oncology | Degarelix Acetate | 934016-19-0 |
| Abarelix Acetate | 183552-38-7 | |
| Endocrine | Octreotide Acetate | 79517-01-4 |
| Exenatide | 141758-74-9 | |
| Glucagon | 16941-32-5 | |
| Dapiglutide | 1544300-84-6 | |
| Pasireotide | 396091-73-9 | |
| Cetrorelix Acetate | 120287-85-6 | |
| Human Glucagon-like Peptide-1 | 106612-94-6 | |
| Lixisenatide Acetate | 320367-13-3 | |
| Pramlintide Acetate | 196078-30-5 | |
| Lanreotide Acetate | 108736-35-2 | |
| Antide Acetate | 112568-12-4 | |
| Cardiovascular | Eptifibatide | 188627-80-7 |
| Nesiritide | 124584-08-3 | |
| Icatibant Acetate | 138614-30-9 | |
| Eledoisin Acetate | 69-25-0 | |
| Urogenital | Carbetocin | 37025-55-1 |
| Atosiban Acetate | 914453-95-5 | |
| Oxytocin | 50-56-6 | |
| Argipressin | 113-79-1 | |
| Lypressin | 50-57-7 | |
| Gastrointestinal | Terlipressin Acetate | 14636-12-5 |
| Plecanatide | 467426-54-6 | |
| Somatostatin Acetate | 54472-66-1 | |
| Teduglutide | 197922-42-2 | |
| Nervous System | Taltirelin | 103300-74-9 |
| Glatiramer Acetate | 147245-92-9 | |
| Skeletal System | Abaloparatide | 247062-33-5 |
| Vosoritide | 1480724-61-5 | |
| Teriparatide Acetate | 52232-67-4 | |
| Salmon Calcitonin | 47931-85-1 | |
| Respiratory | Aviptadil Acetate | 40077-57-4 |
| Infectious Diseases | Thymalfasin | 69440-99-9 |
| Enfuvirtide | 159519-65-0 |
← Swipe horizontally to view the full table →
Disclaimer: Patent-protected or not-yet-approved products are for scientific research, experiments and other non-commercial uses only.
Please provide product name, CAS, demand scale and intended use. We will respond within one business day.
